Neuronetics, Inc. (STIM)

USD 4.58

(2.69%)

Revenue Summary of Neuronetics, Inc.

  • Neuronetics, Inc.'s latest annual revenue in 2023 was 71.34 Million USD , up 9.42% from previous year.
  • Neuronetics, Inc.'s latest quarterly revenue in 2024 Q2 was 16.45 Million USD , down -5.55% from previous quarter.
  • Neuronetics, Inc. reported a annual revenue of 65.2 Million USD in annual revenue 2022, up 17.89% from previous year.
  • Neuronetics, Inc. reported a annual revenue of 55.31 Million USD in annual revenue 2021, up 12.32% from previous year.
  • Neuronetics, Inc. reported a quarterly revenue of 17.41 Million USD for 2024 Q1, down -14.26% from previous quarter.
  • Neuronetics, Inc. reported a quarterly revenue of 17.88 Million USD for 2023 Q3, up 1.56% from previous quarter.

Annual Revenue Chart of Neuronetics, Inc. (2023 - 2016)

Historical Annual Revenue of Neuronetics, Inc. (2023 - 2016)

Year Revenue Revenue Growth
2023 71.34 Million USD 9.42%
2022 65.2 Million USD 17.89%
2021 55.31 Million USD 12.32%
2020 49.24 Million USD -21.41%
2019 62.65 Million USD 18.72%
2018 52.77 Million USD 30.53%
2017 40.43 Million USD 18.13%
2016 34.22 Million USD 0.0%

Peer Revenue Comparison of Neuronetics, Inc.

Name Revenue Revenue Difference
Aclaris Therapeutics, Inc. 31.24 Million USD -128.321%
Biodesix, Inc. 49.08 Million USD -45.35%
bioAffinity Technologies, Inc. 2.53 Million USD -2717.296%
Castle Biosciences, Inc. 219.78 Million USD 67.538%
DarioHealth Corp. 20.35 Million USD -250.57%
Exact Sciences Corporation 2.49 Billion USD 97.146%
IDEXX Laboratories, Inc. 3.66 Billion USD 98.051%
Illumina, Inc. 4.5 Billion USD 98.416%
Intelligent Bio Solutions Inc. 3.11 Million USD -2192.835%
iSpecimen Inc. 9.92 Million USD -618.641%
Standard BioTools Inc. 106.34 Million USD 32.906%
23andMe Holding Co. 219.63 Million USD 67.516%
Medpace Holdings, Inc. 1.88 Billion USD 96.217%
NeoGenomics, Inc. 591.64 Million USD 87.941%
Inotiv, Inc. 572.42 Million USD 87.536%
Psychemedics Corporation 22.09 Million USD -222.871%
Prenetics Global Limited 21.74 Million USD -228.147%
Precipio, Inc. 15.19 Million USD -369.487%
RadNet, Inc. 1.61 Billion USD 95.587%
Sotera Health Company 1.04 Billion USD 93.2%
Star Equity Holdings, Inc. 45.78 Million USD -55.833%
Exagen Inc. 52.54 Million USD -35.777%
Natera, Inc. 1.08 Billion USD 93.409%
Aspira Women's Health Inc. 9.15 Million USD -679.419%
Neogen Corporation 924.22 Million USD 92.28%
Myriad Genetics, Inc. 678.4 Million USD 89.483%
ICON Public Limited Company 8.12 Billion USD 99.121%
Bionano Genomics, Inc. 36.11 Million USD -97.552%
CareDx, Inc 280.32 Million USD 74.548%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 312.97 Million USD 77.203%
Guardant Health, Inc. 563.94 Million USD 87.348%
BioNexus Gene Lab Corp. 9.77 Million USD -630.216%
Fulgent Genetics, Inc. 289.21 Million USD 75.33%
Sera Prognostics, Inc. 306 Thousand USD -23216.34%
OPKO Health, Inc. 863.49 Million USD 91.737%
Personalis, Inc. 73.48 Million USD 2.903%
Applied DNA Sciences, Inc. 13.36 Million USD -433.745%
Star Equity Holdings, Inc. 45.78 Million USD -55.833%
MDxHealth SA 70.19 Million USD -1.645%
Prenetics Global Limited 21.74 Million USD -228.147%
ENDRA Life Sciences Inc. - USD -Infinity%
Mainz Biomed B.V. 895.47 Thousand USD -7867.579%
Trinity Biotech plc 56.83 Million USD -25.542%
bioAffinity Technologies, Inc. 2.53 Million USD -2717.296%